Novartis Investigative Site

Candiolo, Piedmont 10060

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). — Completed